Research Partnership publishes new patient Living with Ankylosing Spondylitis & nr-axSpA EU & US 2019 reports
Living with Ankylosing Spondylitis (AS) & nr-AxSpA are reports based on quantitative studies conducted online in the 5EU and US. The AS 5EU report comprises of interviews with 385 patients in France, Germany, Italy, Spain and UK, while the AS US report is based on a study of 136 patients. The Living with nr-AxSpA report comprises of interviews with a total of 78 patients in the 5EU and the US. All of the studies consist of 30-minute quantitative online interviews and for the AS studies 30 minute qualitative tele-depth interviews. The reports are available to purchase in the following formats: AS (5EU), AS (US) and nr-AxSpA (5EU & US).
AS is a form of progressive arthritis due to chronic inflammation of the joints in the spine. Most patients typically first experience AS symptoms in their teen years up to the age of 30 years old, meaning symptoms impact AS patients for a long period of time into their adult years.
These reports enable pharmaceutical companies developing products in AS and nr-AxSpA to gain a deeper understanding of how patients come to be diagnosed with their disease and how their condition impacts their day-to-day lives physically, emotionally and socially. It also explores patient attitudes and perceptions towards treatment, the healthcare professionals managing their condition, as well as identifying the types of support and education patients need at key stages of their journey.
Head of Living With, Mariel Metcalfe commented, “People living with AS and nr-AxSpa experience high levels of unmet need, and diagnosis can be lengthy for some. These reports focus on not only the experiences of these people, but also what more can be done to help support them medically, emotionally and socially.”
The Living with Atopic Dermatitis - AD (US & EU), Crohn’s (EU & US), Diabetes (LATAM), Lupus - SLE (EU & US), Non-alcoholic Steatohepatitis - NASH (EU & US), Psoriasis - PsO (EU), Psoriatic arthritis - PsA (EU), Rheumatoid Arthritis - RA (US, EU, Japan & Canada) and Ulcerative Colitis - UC (EU & US) reports are also published and available to purchase.
Sign up to receive Rapport
Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here »